The article argues that investing $10,000 in USA Rare Earth (USAR) could be worthwhile for long-term wealth building but is unlikely to turn into $1 million on its own. Reaching $1 million would require a 100-fold return, implying a $380 billion valuation from its current market cap of about $3.8 billion, which the author considers unlikely given limited demand and competition from MP Materials (MP). The company holds the Round Top deposit in Texas, plans magnet manufacturing in Oklahoma and rare earth production from a mine in Brazil. The author says he would not expect to become a millionaire but might consider adding shares to a diversified portfolio for potential long-term upside.
Summary written by Upside AI from the original article. Read the source for full details.
Read the original on Yahoo Finance ↗
Keywords
USA Rare Earthrare earthsminingMP Materials
Open a keyword to see other news on the same topic.
Related news
- USA Rare Earth Climbs 4% as Month-Long Selloff Pauses; MP Materials Ticks Up, United States Antimony Dips
USA Rare Earth (USAR) rose 4% to $10.77 as a month-long selloff in domestic rare earth stocks paused, though the shares are still down 31% over the past month. United States Antimony (UAMY) slipped 0.9% to $2.76, MP Materials (MP) gained 2% to $40.82, and the VanEck Rare Earth and Strategic Metals ETF (REMX) fell 0.9% to $55.26, while the SPDR S&P 500 ETF Trust (SPY) rose 0.1% to $770.43. The article notes USA Rare Earth is building capacity to process rare earths and produce magnets, so its value depends on plants that have not yet started production. Its government-backed funding is released in stages tied to construction and production milestones, making project progress central to the stock.
- USA Rare Earth: Millionaire Maker or Market Hype? The Honest Truth.
The article examines USA Rare Earth (USAR), a US mining company that owns the Round Top deposit in Texas and aims to become a vertically integrated rare-earth producer, from mining to permanent magnets. Round Top is not yet operating and commercial production is targeted for late 2028, while the company has a magnet factory in Stillwater, Oklahoma and has acquired Serra Verde and Less Common Metals. The company is still burning cash and barely generating revenue, although the White House has given it access to up to $1.6 billion in funding and it says it is in talks with over 100 potential customers. The author argues the stock is not empty hype, but calling it a millionaire maker seems premature because the company has not yet turned a profit or manufactured magnets at scale.
- Is MP Materials Stock a Millionaire Maker?
The article asks whether MP Materials stock can make investors millionaires, noting the company's valuation of nearly $7 billion and a 22.7% share price decline since January. The author calls the stock speculative, with potential for large moves on news about expanding the Mountain Pass rare-earth site in California. Last quarter, NdPr production reached 840 metric tons, up 41% year over year, while NdPr sales rose 127% to 1,006 metric tons; the company also plans major magnet shipments to General Motors and Apple in Q4 2026 and Q1 2027. MP Materials reports earnings on Nov. 5, but the author notes much of its future potential is already reflected in its valuation and forecasts only reach $1 billion in sales two years out. The author suggests considering a small speculative position, as execution risks remain.
- MP vs. LYSDY: Which Rare Earth Stock Has an Edge Right Now?
MP Materials (US) and Lynas Rare Earths (Australia) are both expanding rare earth and permanent magnet production as Western countries seek to reduce reliance on Chinese supply. MP, with a market capitalization of $7 billion, is the only fully integrated rare earth producer in the US; its second-quarter 2026 revenue rose 89% year over year to $108.5 million and NdPr output rose 41% to 840 metric tons, but cost of sales climbed 43.3% and start-up costs rose to $14.4 million from $0.76 million. Lynas, valued at around $8 billion, reported fiscal 2026 revenue up 76% to AUD 977.9 million ($680.5 million) and adjusted EBITDA up 281% to AUD 386 million ($268.6 million). The article says differences in operational execution, profitability and valuation warrant a closer look before investors choose between the two stocks.
- Rare Earths vs. Copper: Should You Buy MP Materials or Freeport-McMoRan?
The article compares MP Materials, a top domestic rare-earth producer, with Freeport-McMoRan, a major copper producer, as both benefit from data center and power grid build-outs. MP operates the Mountain Pass Mine, the only scaled rare-earth mining and processing site in the U.S., and has a Department of Defense price floor of $110/kilogram for NdPr plus a 10-year agreement guaranteeing at least $140 million of annual EBITDA for its second magnet campus. Freeport accounts for about 70% of U.S. refined copper production and is on pace to produce 3.1 billion pounds of copper this year, while S&P Global projects global copper demand could grow 50% by 2040. The author suggests Freeport suits investors seeking a more established business, while MP's binding DoD agreement and price floor offer earnings visibility and downside protection. Copper deficits are expected to persist through the end of the decade.
- Is MP Materials Stock Still a Buy After Its Recent Pullback?
MP Materials has fallen more than 50% since last October, even though it remains one of the few American companies that can mine and refine rare earths and still receives US government support, including a price floor for NdPR and a 10-year agreement to buy magnets from its planned 10X facility. Second-quarter revenue rose 80% year over year to roughly $109 million, and revenue is expected to more than double over the next two years. The author says the price-to-sales ratio has dropped from about 70 times in late 2025 to around 17 today, still above other mining stocks, so the stock may be volatile in the short term. The author does not view it as suitable for money needed over the next five years, but says long-term investors could see a handsome gain.
Related markets
Latest news
- Argentina drops criminal probe into President Milei over crashed memecoin LIBRA
An Argentine federal judge dismissed the criminal case against President Javier Milei over his promotion of the memecoin LIBRA, ruling that his endorsement and the token's later collapse did not establish fraud without evidence of a specific deception. Eleven people were cleared, including Milei's sister Karina and U.S. businessman Hayden Davis, though none had been formally questioned. LIBRA lost more than 95% of its value after reaching about $5, while eight wallets linked to its creator withdrew around $99 million in crypto. The presidency called the probe an attempt to harm Milei's reputation, and the prosecutor is not expected to appeal. Investors who were removed as plaintiffs are challenging that decision, and if reinstated they could appeal the dismissal.
- Vanguard Morningstar Growth ETF vs. Vanguard Information Technology ETF: Here's Which One I Believe Is the Clear Long-Term Winner.
The article compares two Vanguard ETFs: the Vanguard Morningstar Growth ETF (VUG), which holds 135 large-cap growth stocks at a 0.03% expense ratio, and the Vanguard Information Technology ETF (VGT), which holds 318 U.S. tech stocks at 0.09%. Over the past decade, VGT returned 775% versus 420% for VUG, and a hypothetical $10,000 investment in VGT would be worth almost $88,000. Both funds have benefited from the AI boom, but VGT is more concentrated in Nvidia, Apple and Microsoft and has a 38% semiconductor weighting, while VUG offers more sector diversification. The author, who has 30 years until retirement, chooses VGT for its long-term potential, and says investors seeking less aggressive exposure could allocate 5% to 10% of their portfolios to it.
- Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer
A late-stage trial found that adding Amgen's Imdelltra to AstraZeneca's Imfinzi cut the risk of death by 58% in patients with extensive-stage small cell lung cancer. Median overall survival rose to 21.1 months, compared with 12.7 months for Imfinzi alone, in patients whose cancer had not progressed after initial Imfinzi and chemotherapy. Nearly 80% of patients on the combination were alive at one year, versus 53% on Imfinzi alone. Imdelltra posted $288 million in second-quarter sales, up 115% year over year, after $627 million in global sales in 2025. Amgen said the results suggest earlier use of the drug could meaningfully alter the course of the disease, though the trial did not compare the combination with other first-line treatments.
- AMC Stock: You Can See Everything
AMC Entertainment's stock is up 86% in 2026 as domestic box office receipts rise 21% from a year earlier, helped by A24's documentary You Can See Everything. The film took in $15.7 million in ticket sales over its opening weekend from just 855 screens, the strongest opening for a non-musical documentary in more than 20 years, and is expanding to more than 2,500 screens. Analysts expect AMC's revenue to rise 18% to $5.7 billion, and the chain could post positive adjusted earnings for the first time since 2018. The author says the business has improved on fundamentals such as concessions and its loyalty program, but notes the stock is still down 99.2% over the past year. The author is willing to take the risk on the shares, arguing the current rally reflects improving fundamentals rather than hype.
- Banks agree to inject 230 trillion VND into businesses and projects: Which names are worth watching?
At the 23 October 2026 conference organised by the State Bank of Vietnam and the HCMC People's Committee, banks and businesses signed 20 cooperation agreements worth about 230 trillion VND in total. The projects span manufacturing, energy, pharmaceuticals, transport infrastructure, industrial parks and social housing. Notable deals include BIDV and VietinBank co-financing PTSC's EPIC 1 package for the Maydan Mahzam field redevelopment, worth 2.8 billion USD, and Agribank financing 4,867 billion VND for an expressway section of HCMC's Ring Road 4. Vietcombank is providing 1,113 billion VND for Becamex's social housing projects, ACB 500 billion VND for Central Medicinal Materials JSC 2, and HDBank and Vikki Bank are co-financing 50,000 billion VND for the VIFC-HCMC project cluster.
- Tesla (TSLA) Q3 Earnings Reveal A Sharper Margin Squeeze
Tesla reported Q3 2026 earnings per share of US$0.24 and net income of US$787m, with revenue roughly flat year over year at US$28,046m. Net income fell 42.7% from US$1,373m a year earlier, and the trailing 12-month net margin compressed to 3.1% from 5.3%. Services and other margins hit a record 15.9%, and FSD has over 1.7 million paying users with a North American attach rate above 75%. Optimistic investors expect AI and robotics to become recurring high-margin revenue, while cautious investors warn that capex above US$25b a year could strain free cash flow and delay returns. Shares slipped about 0.6% in the latest session.
Get the briefing on Telegram or Zalo
Join the Upside Telegram channel or Zalo group for the Vietnam stocks and gold briefing at 8:00 and 19:00 (Vietnam time) on trading days, plus a weekly wrap on Saturday morning.